Booth no: Za’abeel Hall Z6.C40 VibroSense presents new ultra sensitive systems for measuring diabetic and other neuropathies at Arab Health 2017
Easy to use devices provide early warning of diabetic foot ulcers (DFU) and chemotherapy-induced peripheral neuropathies (CIPN)Swedish medical device company VibroSense today showed its range of ultra-sensitive systems at Arab Health 2017. Already widely used in the construction, mining and other industries for diagnosing occupational health injuries, CE-marked VibroSense Meters are currently being introduced for a range of clinical applications. All systems utilize an innovative method called Multi-Frequency Vibrometry which provides an accurate measure of sensory perception in patient